The research progress of the association of mitochondrial DNA mutation with cardiomyopathy.
- Author:
Jian Ju LU
1
;
Hui Ling LU
Author Information
1. Department of Forensic Serology, Sun Yat-sen University of Medical Sciences, Guangzhou 510089. lujianju@eyou.com
- Publication Type:Review
- MeSH:
Cardiomyopathy, Hypertrophic/genetics*;
DNA, Mitochondrial/genetics*;
Humans;
Myocardial Ischemia/genetics*;
Point Mutation
- From:
Journal of Forensic Medicine
2001;17(4):242-248
- CountryChina
- Language:Chinese
-
Abstract:
There are some human diseases associated with mitochondrial DNA genome defect. Now many studies think that: oxygen radical resulting from oxidative phosphorylation(OXPHOS) disorder caused by myocardium ischemia and the increased OXPHOS induction damage mitochondrial DNA. Chronic damage accumulations lead to mitochondrial DNA deletion or point mutation in the end which show mitochondrial DNA 5.0 kb or 7.4 kb deletion and point mutation at position C15452A in the cytochrome b gene; the conservative sequence mutation of tRNA gene such as A4300G, C4320T point mutation in the tRNA Ilegene, A3243G point mutation in the tRNA leu gene etc result in defective contractile proteins whose persistent and inefficient contraction may increase the myocardium's metabolic demands for ATP and leads to cardiac hypertrophy. In this article, we review the study on the association of mitochondrial DNA mutation with ischemic cardiomyopathy and hypertrophic cardiomyopathy.
